Inventor · disambiguated record
Kenneth L. Duchin
Also filed as: DUCHIN KENNETH L
11 granted patents·19 pending applications·239 citations·filing 1996–2016
92Inventor score
Top patents by PatentIndex Score
30 records- 0189US6610735B2Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agentsBAKER NORTON PHARMA·Filed 2001·Granted Aug 26, 2003·23 cites·106 claims
- 0288US6245805B1Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agentsBAKER NORTON PHARMA·Filed 1996·Granted Jun 12, 2001·52 cites·53 claims
- 0388US5968972AMethod for increasing the oral bioactivity of pharmaceutical agentsBAKER NORTON PHARMA·Filed 1996·Granted Oct 19, 1999·82 cites·40 claims
- 0484US6730698B2Method and compositions for administering taxanes orally to human patientsBAKER NORTON PHARMA·Filed 2002·Granted May 4, 2004·12 cites·92 claims
- 0583US9132124B2Combinations of solifenacin and salivary stimulants for the treatment of overactive bladderPABORJI MEHDI·Filed 2012·Granted Sep 15, 2015·7 cites·6 claims
- 0683US8940763B2Combinations of solifenacin and salivary stimulants for the treatment of overactive bladderPABORJI MEHDI·Filed 2012·Granted Jan 27, 2015·7 cites·11 claims
- 0782US9744157B2Combinations of solifenacin and salivary stimulants for the treatment of overactive bladderTHERAVIDA INC·Filed 2015·Granted Aug 29, 2017·4 cites·6 claims
- 0881US6818615B2Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agentsBAKER NORTON PHARMA·Filed 2002·Granted Nov 16, 2004·9 cites·103 claims
- 0977US7041640B2Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agentsBAKER NORTON PHARMA·Filed 2004·Granted May 9, 2006·6 cites·181 claims
- 1076US6395770B1Method and compositions for administering taxanes orally to human patientsBAKER NORTON PHARMA·Filed 1999·Granted May 28, 2002·34 cites·30 claims
- 1174US6936583B2Method and compositions for administering taxanes orally to human patientsBAKER NORTON PHARMA·Filed 2004·Granted Aug 30, 2005·3 cites·55 claims
- 1261US2007060635A1Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agentsTEVA NORTH AMERICA·Filed 2006·Application pending·0 cites
- 1359US2014194454A1Combinations of trospium and salivary stimulants for the treatment of overactive bladderPABORJI MEHDI·Filed 2014·Application pending·0 cites
- 1458US2013296392A1Methods for the treatment of overactive bladderTHERAVIDA INC·Filed 2013·Application pending·0 cites
- 1558US2005238634A1Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agentsBAKER NORTON PHARMA·Filed 2005·Application pending·0 cites
- 1655US2012289531A1Combinations of trospium and salivary stimulants for the treatment of overactive bladderPABORJI MEHDI·Filed 2012·Application pending·0 cites
- 1755US2012289529A1Combinations of trospium and salivary stimulants for the treatment of overactive bladderPABORJI MEHDI·Filed 2012·Application pending·0 cites
- 1855US2012289530A1Combinations of trospium and salivary stimulants for the treatment of overactive bladderPABORJI MEHDI·Filed 2012·Application pending·0 cites
- 1955US2012289566A1Combinations of fesoterodine and salivary stimulants for the treatment of overactive bladderPABORJI MEHDI·Filed 2012·Application pending·0 cites
- 2055US2012289539A1Combinations of trospium and salivary stimulants for the treatment of overactive bladderPABORJI MEHDI·Filed 2012·Application pending·0 cites
- 2154US2017258767A1Methods for the treatment of overactive bladderTHERAVIDA INC·Filed 2016·Application pending·0 cites
- 2254US2012289564A1Combinations of oxybutynin and salivary stimulants for the treatment of overactive bladderPABORJI MEHDI·Filed 2012·Application pending·0 cites
- 2346US2012289561A1Combinations of fesoterodine and salivary stimulants for the treatment of overactive bladderPABORJI MEHDI·Filed 2012·Application pending·0 cites
- 2445US2012289567A1Combinations of darifenacin and salivary stimulants for the treatment of overactive bladderPABORJI MEHDI·Filed 2012·Application pending·0 cites
- 2545US2012289562A1Combinations of darifenacin and salivary stimulants for the treatment of overactive bladderPABORJI MEHDI·Filed 2012·Application pending·0 cites
- 2645US2012289560A1Combinations of tolterodine and salivary stimulants for the treatment of overactive bladderPABORJI MEHDI·Filed 2012·Application pending·0 cites
- 2745US2012289565A1Combinations of tolterodine and salivary stimulants for the treatment of overactive bladderPABORJI MEHDI·Filed 2012·Application pending·0 cites
- 2845US2012289547A1Combinations of propiverine and salivary stimulants for the treatment of overactive bladderPABORJI MEHDI·Filed 2012·Application pending·0 cites
- 2945US2012289568A1Combinations of oxybutynin and salivary stimulants for the treatment of overactive bladderPABORJI MEHDI·Filed 2012·Application pending·0 cites
- 3038US2012289563A1Combinations of imidafenacin and salivary stimulants for the treatment of overactive bladderPABORJI MEHDI·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kenneth L. Duchin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →